According to TechFlame, Strategic ETH Reserve posted an article on the X platform stating that the Nasdaq-listed Ethereum treasury company EthZilla (formerly 180 Life Sciences Corp.) has revised the sales agreement previously signed with Clear Street, involving the issuance of common shares with a face value of $0.0001 per share in the supplementary prospectus and in the attached prospectus. Under the terms of the revised sale agreement, the company will be able to raise up to $10,000,000,000 by issuing and selling common shares to support its continued purchase of ETH.